Home Stock

Stock Research: Sawai Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Sawai Pharmaceutical

TYO:4887 JP3323050009
73
  • Value
    90
  • Growth
    83
  • Safety
    Safety
    46
  • Combined
    85
  • Sentiment
    34
  • 360° View
    360° View
    73
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Sawai Group Holdings Co Ltd manufactures and sells medical and over-the-counter drugs. They operate in pharmaceutical and medical device manufacturing and sales, and R&D. Key regions include Japan and America. In the last fiscal year, the company had 3310 employees, a market cap of $1489 million, profits of $376 million, and revenue of $1261 million.

more

ANALYSIS: With an Obermatt 360° View of 73 (better than 73% compared with alternatives), overall professional sentiment and financial characteristics for the stock Sawai Pharmaceutical are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Sawai Pharmaceutical. The consolidated Value Rank has an attractive rank of 90, which means that the share price of Sawai Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 90% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 83, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 34. Professional investors are more confident in 66% other stocks. Worryingly, the company has risky financing, with a Safety rank of 46. This means 54% of comparable companies have a safer financing structure than Sawai Pharmaceutical. ...read more

more
Strongest Rank Market Pulse
Weakest Rank Pro Holdings
Country Japan
Industry Pharmaceuticals
Size Large
Website sawaigroup.holdings
Index
Sawai Pharmaceutical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 23-Jun-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
90 86 92 100
Growth
83 59 39 51
Safety
Safety
46 61 72 70
Sentiment
34 86 82 25
360° View
360° View
73 98 98 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
37 40 44 28
Opinions Change
38 70 82 50
Pro Holdings
n/a 92 82 39
Market Pulse
1 65 54 44
Sentiment
34 86 82 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
90 86 92 100
Growth
83 59 39 51
Safety Safety
46 61 72 70
Combined
85 86 92 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
80 76 91 97
Price vs. Earnings (P/E)
39 81 74 97
Price vs. Book (P/B)
80 78 71 93
Dividend Yield
87 65 82 92
Value
90 86 92 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
22 36 37 43
Profit Growth
81 79 50 81
Capital Growth
90 34 18 24
Stock Returns
66 74 77 49
Growth
83 59 39 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
31 27 33 36
Refinancing
67 76 89 89
Liquidity
55 59 59 53
Safety Safety
46 61 72 70

Similar Stocks

Discover high‑ranked alternatives to Sawai Pharmaceutical and broaden your portfolio horizons.

Brother Industries

TYO:6448
Country: Japan
Industry: Technology Hardware & Peripherals
Size: X-Large
Full Stock Analysis

Ushio

TYO:6925
Country: Japan
Industry: Electr. Components & Equipment
Size: Large
Full Stock Analysis

Nippon Electric Glass

TYO:5214
Country: Japan
Industry: Electronic Components
Size: Large
Full Stock Analysis

Resorttrust

TYO:4681
Country: Japan
Industry: Hotels, Resorts & Cruise Lines
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a mixed bag with good value and high growth balanced by risky financing and negative sentiment. This is a risky stock that requires conviction; you should only consider it if you are willing to conduct further research into the underlying sentiment and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews